Kardan-Yamchi, J., Amini, S., Hamzelou, G., Rahimi Foroushani, A., Ghodousi, A., Cirillo, D. M., & Feizabadi, M. M. (2021). Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates. Archives of microbiology, 203(7), 3989-3996. https://doi.org/10.1007/s00203-021-02387-3
Chicago Style (17th ed.) CitationKardan-Yamchi, Jalil, Sirus Amini, Gholamreza Hamzelou, Abbas Rahimi Foroushani, Arash Ghodousi, Daniela Maria Cirillo, and Mohammad Mehdi Feizabadi. "Assessment of the GenoType MTBDRsl VER 2.0 Compared to the Phenotypic Drug Susceptibility Testing and Whole Genome Sequencing for the Rapid Detection of Resistance to Fluoroquinolone and Second-line Injectable Drugs Among Rifampicin-resistant Mycobacterium Tuberculosis Isolates." Archives of Microbiology 203, no. 7 (2021): 3989-3996. https://doi.org/10.1007/s00203-021-02387-3.
MLA (9th ed.) CitationKardan-Yamchi, Jalil, et al. "Assessment of the GenoType MTBDRsl VER 2.0 Compared to the Phenotypic Drug Susceptibility Testing and Whole Genome Sequencing for the Rapid Detection of Resistance to Fluoroquinolone and Second-line Injectable Drugs Among Rifampicin-resistant Mycobacterium Tuberculosis Isolates." Archives of Microbiology, vol. 203, no. 7, 2021, pp. 3989-3996, https://doi.org/10.1007/s00203-021-02387-3.